Literature DB >> 32595131

Light chain proximal tubulopathy with cast nephropathy in monoclonal gammopathy of renal significance.

Rebaika Chopra1, Rosalba Santana de Roberts2, Ibrahim Batal3, Sachin Batra1, Belinda Jim4.   

Abstract

Kidney tubular disorders due to monoclonal immunoglobulin light chains are common manifestations of B-cell neoplasm. Cast nephropathy (CN) is the most frequent type of these disorders and may present with acute kidney injury (AKI) due to the presence of excess light chains in the distal tubules. Light chain proximal tubulopathy (LCPT) is an uncommon form of renal disease and may present as Fanconi syndrome due to proximal tubular cell damage by intracellular deposition of light chains. The concomitant disorder of both CN and LCPT is rare given the inherent differences in the biochemical properties of the immunoglobulin light chains of each disorder. We report a 64-year-old man who presented with AKI and Fanconi syndrome who was discovered to have both CN and LCPT due to the underlying disorder of monoclonal gammopathy of renal significance and who has responded favourably with conventional chemotherapy. We also review the existing literature on this interesting subject. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute renal failure; chemotherapy; haematology (incl blood transfusion); proteinurea; renal system

Mesh:

Substances:

Year:  2020        PMID: 32595131      PMCID: PMC7322277          DOI: 10.1136/bcr-2020-234361

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  Multiple myeloma.

Authors:  Stephen M Korbet; Melvin M Schwartz
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

Review 2.  Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients.

Authors:  T Messiaen; S Deret; B Mougenot; F Bridoux; P Dequiedt; J J Dion; R Makdassi; F Meeus; J Pourrat; G Touchard; P Vanhille; P Zaoui; P Aucouturier; P M Ronco
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

3.  Mechanism and prevention of acute kidney injury from cast nephropathy in a rodent model.

Authors:  Wei-Zhong Ying; Christopher E Allen; Lisa M Curtis; Kristal J Aaron; Paul W Sanders
Journal:  J Clin Invest       Date:  2012-04-09       Impact factor: 14.808

4.  Trifecta of light chain cast nephropathy, monoclonal plasma cell infiltrates, and light chain proximal tubulopathy.

Authors:  Abhilash Koratala; A Ahsan Ejaz; Wesley M Hiser; William L Clapp
Journal:  Kidney Int       Date:  2017-12       Impact factor: 10.612

5.  Review of 1027 patients with newly diagnosed multiple myeloma.

Authors:  Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616

6.  Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies.

Authors:  M Leboulleux; B Lelongt; B Mougenot; G Touchard; R Makdassi; A Rocca; L H Noel; P M Ronco; P Aucouturier
Journal:  Kidney Int       Date:  1995-07       Impact factor: 10.612

7.  Light chain proximal tubulopathy with cast nephropathy in a case of multiple myeloma.

Authors:  K K Gowda; K Joshi; R Nada; R Ramachandran; M Sachdeva
Journal:  Indian J Nephrol       Date:  2015 Mar-Apr

8.  Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.

Authors:  Chung-Kuan Wu; An-Hang Yang; Hung-Chih Lai; Bing-Shi Lin
Journal:  BMC Nephrol       Date:  2017-05-25       Impact factor: 2.388

9.  Lambda Light Chain Crystalline Cast Nephropathy and Proximal Tubulopathy.

Authors:  Alexander J Gallan; Mazdak A Khalighi
Journal:  Kidney Int Rep       Date:  2016-08-12

10.  Lambda Light Chain Non-crystalline Proximal Tubulopathy with IgD Lambda Myeloma.

Authors:  Seiji Kishi; Fumiaki Obata; Hirokazu Miki; Motokazu Matsuura; Kenji Nishimura; Masanori Tamaki; Fumi Kishi; Taichi Murakami; Hideharu Abe; Kojiro Nagai; Masahiro Abe; Toshio Doi
Journal:  Intern Med       Date:  2018-08-10       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.